Logo image of CLRO

CLEARONE INC (CLRO) Stock Fundamental Analysis

NASDAQ:CLRO - Nasdaq - US18506U1043 - Common Stock - Currency: USD

5.84  -0.17 (-2.83%)

Fundamental Rating

2

CLRO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 49 industry peers in the Communications Equipment industry. CLRO has a great financial health rating, but its profitability evaluates not so good. CLRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CLRO has reported negative net income.
In the past year CLRO has reported a negative cash flow from operations.
The reported net income has been mixed in the past 5 years: CLRO reported negative net income in multiple years.
CLRO had negative operating cash flow in 4 of the past 5 years.
CLRO Yearly Net Income VS EBIT VS OCF VS FCFCLRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

Looking at the Return On Assets, with a value of -40.19%, CLRO is doing worse than 83.67% of the companies in the same industry.
The Return On Equity of CLRO (-50.83%) is worse than 69.39% of its industry peers.
Industry RankSector Rank
ROA -40.19%
ROE -50.83%
ROIC N/A
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
CLRO Yearly ROA, ROE, ROICCLRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

CLRO has a worse Gross Margin (15.87%) than 95.92% of its industry peers.
In the last couple of years the Gross Margin of CLRO has declined.
CLRO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 15.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
CLRO Yearly Profit, Operating, Gross MarginsCLRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

8

2. Health

2.1 Basic Checks

CLRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLRO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CLRO has more shares outstanding
There is no outstanding debt for CLRO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CLRO Yearly Shares OutstandingCLRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CLRO Yearly Total Debt VS Total AssetsCLRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 17.13 indicates that CLRO is not in any danger for bankruptcy at the moment.
CLRO's Altman-Z score of 17.13 is amongst the best of the industry. CLRO outperforms 95.92% of its industry peers.
CLRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 17.13
ROIC/WACCN/A
WACC9.78%
CLRO Yearly LT Debt VS Equity VS FCFCLRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 4.81 indicates that CLRO has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 4.81, CLRO belongs to the top of the industry, outperforming 89.80% of the companies in the same industry.
A Quick Ratio of 2.03 indicates that CLRO has no problem at all paying its short term obligations.
The Quick ratio of CLRO (2.03) is better than 75.51% of its industry peers.
Industry RankSector Rank
Current Ratio 4.81
Quick Ratio 2.03
CLRO Yearly Current Assets VS Current LiabilitesCLRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CLRO have decreased strongly by -494.78% in the last year.
Looking at the last year, CLRO shows a very negative growth in Revenue. The Revenue has decreased by -44.47% in the last year.
CLRO shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.58% yearly.
EPS 1Y (TTM)-494.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.57%
Revenue 1Y (TTM)-44.47%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-36.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLRO Yearly Revenue VS EstimatesCLRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CLRO Yearly EPS VS EstimatesCLRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 0 0.2 0.4 0.6 0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CLRO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLRO Price Earnings VS Forward Price EarningsCLRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLRO Per share dataCLRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CLRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEARONE INC

NASDAQ:CLRO (6/11/2025, 3:52:16 PM)

5.84

-0.17 (-2.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-12 2025-08-12
Inst Owners6.12%
Inst Owner Change-5.65%
Ins Owners0.25%
Ins Owner Change14.52%
Market Cap151.78M
Analysts85.71
Price TargetN/A
Short Float %0.43%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.6
Dividend Growth(5Y)24.47%
DP-146.14%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.06
P/FCF N/A
P/OCF N/A
P/B 7.78
P/tB 8.43
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.31
OCFYN/A
SpS0.39
BVpS0.75
TBVpS0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -40.19%
ROE -50.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 15.87%
FCFM N/A
ROA(3y)-3.47%
ROA(5y)-4.24%
ROE(3y)-5.21%
ROE(5y)-5.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-17.52%
GM growth 5Y-12.37%
F-Score4
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.37%
Cap/Sales 2.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.81
Quick Ratio 2.03
Altman-Z 17.13
F-Score4
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)26.17%
Cap/Depr(5y)23.5%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-494.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-44.47%
Revenue growth 3Y-26.75%
Revenue growth 5Y-14.58%
Sales Q2Q%-36.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-114.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.97%
OCF growth 3YN/A
OCF growth 5YN/A